Education
About Us
Working with TipRanks
Follow Us
Simrat Randhawa Insider Profile
4 Followers
Simrat Randhawa, EVP, Head of R&D at Dianthus Therapeutics, holds 4.00K shares in Dianthus Therapeutics (Ticker: DNTH).
Simrat Randhawa has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Simrat Randhawa's holdings
Insider Roles
EVP, Head of R&D
Roles that Simrat Randhawa holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 25, 2023 - Sep 25, 2024
Return:+105.30%
The most profitable trade made by Simrat Randhawa
Simrat Randhawa's Trading History
List of latest transactions for each holding click on a transaction to see Simrat Randhawa's performance on stock
You May Also Like
Simrat Randhawa insider profile FAQ
What is the percentage of profitable transactions made by Simrat Randhawa?
The percentage of profitable transactions made by Simrat Randhawa is ―.
What is the average return per transaction made by Simrat Randhawa?
The average return per transaction made by Simrat Randhawa is ―.
What stocks does Simrat Randhawa hold?
Simrat Randhawa holds: DNTH stocks.
What was Simrat Randhawa’s latest transaction?
Simrat Randhawa latest transaction was an Uninformative Buy of $3.00M.
What was Simrat Randhawa's most profitable transaction?
Simrat Randhawa’s most profitable transaction was an Informative Buy of DNTH stock on September 25, 2023. The return on the trade was 105.30%.
What is Simrat Randhawa's role in Dianthus Therapeutics?
Simrat Randhawa's role in Dianthus Therapeutics is EVP, Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.